25682263|t|Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype.
25682263|a|Accumulation of beta-amyloid (Abeta) protein within the brain is a neuropathological hallmark of Alzheimer's disease (AD). One strategy to facilitate Abeta clearance from the brain is to promote Abeta catabolism. Matrix metalloproteinase-9 (MMP-9), a member of the family of Zn(+2)-containing endoproteases, known to be expressed and secreted by astrocytes, is capable of degrading Abeta. Histamine, a major aminergic brain neurotransmitter, stimulates the production of MMP-9 in keratinocytes through the histamine H1 receptor (H1R). In the present study, we show that histamine evokes a concentration- and calcium-dependent release of MMP-9 from human astrocytic U373 cells and primary cultures of human and rat astrocytes through the H1R subtype. Activation of H1R on astrocytes elevated intracellular levels of Ca(2+) that was accompanied by time-dependent increases in MAP kinase p44/p42 and PKC. In-cell western blots revealed dose-dependent increases in both enzymes, confirming involvement of these signal transduction pathways. We next investigated the extent of recombinant human MMP-9 (rhMMP-9) proteolytic activity on soluble oligomeric Abeta (soAbeta). Mass spectrometry demonstrated time-dependent cleavage of soAbeta (20 muM), but not another amyloidogenic protein amylin, upon incubation with rhMMP-9 (100 nM) at 1, 4 and 17 h. Furthermore, Western blots showed a shift in soAbeta equilibrium toward lower order, less toxic monomeric species. In conclusion, both MAPK p44/p42 and PKC pathways appear to be involved in histamine-upregulated MMP-9 release via H1Rs in astrocytes. Furthermore, MMP-9 appears to cleave soAbeta into less toxic monomeric species. Given the key role of histamine in MMP-9 release, this neurotransmitter may serve as a potential therapeutic target for AD.
25682263	0	9	Histamine	Chemical	MESH:D006632
25682263	36	62	matrix metalloproteinase-9	Gene	4318
25682263	66	71	human	Species	9606
25682263	147	152	Abeta	Gene	351
25682263	214	233	Alzheimer's disease	Disease	MESH:D000544
25682263	235	237	AD	Disease	MESH:D000544
25682263	267	272	Abeta	Gene	351
25682263	312	317	Abeta	Gene	351
25682263	330	356	Matrix metalloproteinase-9	Gene	4318
25682263	358	363	MMP-9	Gene	4318
25682263	392	423	Zn(+2)-containing endoproteases	Chemical	-
25682263	499	504	Abeta	Gene	351
25682263	506	515	Histamine	Chemical	MESH:D006632
25682263	588	593	MMP-9	Gene	4318
25682263	623	644	histamine H1 receptor	Gene	3269
25682263	646	649	H1R	Gene	3269
25682263	687	696	histamine	Chemical	MESH:D006632
25682263	725	732	calcium	Chemical	MESH:D002118
25682263	754	759	MMP-9	Gene	4318
25682263	765	770	human	Species	9606
25682263	782	786	U373	CellLine	CVCL:2818
25682263	817	822	human	Species	9606
25682263	827	830	rat	Species	10116
25682263	854	857	H1R	Gene	3269
25682263	881	884	H1R	Gene	3269
25682263	932	938	Ca(2+)	Chemical	-
25682263	1002	1009	p44/p42	Gene	10561;23552
25682263	1014	1017	PKC	Gene	112476
25682263	1201	1206	human	Species	9606
25682263	1207	1212	MMP-9	Gene	4318
25682263	1266	1271	Abeta	Gene	351
25682263	1397	1403	amylin	Gene	3375
25682263	1601	1608	p44/p42	Gene	10561;23552
25682263	1613	1616	PKC	Gene	112476
25682263	1651	1660	histamine	Chemical	MESH:D006632
25682263	1673	1678	MMP-9	Gene	4318
25682263	1724	1729	MMP-9	Gene	4318
25682263	1813	1822	histamine	Chemical	MESH:D006632
25682263	1826	1831	MMP-9	Gene	4318
25682263	1911	1913	AD	Disease	MESH:D000544
25682263	Negative_Correlation	351	4318
25682263	Positive_Correlation	MESH:D006632	4318
25682263	Positive_Correlation	23552	3269
25682263	Positive_Correlation	112476	3269
25682263	Association	MESH:D000544	351
25682263	Positive_Correlation	10561	3269
25682263	Association	3269	4318
25682263	Association	23552	4318
25682263	Association	112476	4318
25682263	Association	MESH:D006632	3269
25682263	Association	MESH:D006632	112476
25682263	Association	10561	4318
25682263	Association	MESH:D006632	MESH:D000544

